Product ID: SQMIG35I2098
Report ID:
SQMIG35I2098 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
121 |
Figures:
77
In March 2022, Visby Medical announced to receive funding of USD 25.5 million from the U.S. Biomedical Advanced Research and Development Authority in order to develop a rapid flu-COVID-19 PCR test for home use. At present, the test is in the under-developing phase and the design is ready as a PCR device that can detect COVID-19, influenza A, and B from a single sample.
March 2022, Canada-based Company, bioLytical Laboratories Inc. received CE marking for the iStatis COVID-19 Antigen Home Test.
April 2021, Siemens Healthineers obtained CE marking for AtellicaVTLi Patient-Side Immunoassay Analyzer. It is one of the first technologies in the industry that aims to enhance the patient care paradigm and offers hs-cTnI results that assist in the diagnosis and treatment of heart attacks.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONPoint Of Care Diagnostics Market was valued at USD 44.9 billion in 2019 and is poised to grow from USD 45.4 billion in 2023 to USD 75.14 billion by 2031, growing at a CAGR of 6.1% in the forecast period (2024-2031).
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35I2098